This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Whitehurst, V. E. Articles by Balazs, T. Search for Related Content PubMed PubMed Citation Articles by Whitehurst, V. E. Articles by Balazs, T. Social Bookmarking                         What's this?

Enhancement of Acute Myocardial Lesions by Asthma Drugs in Rats

Center for Drug Evaluation and Research

Xavier Joseph

Center for Drug Evaluation and Research

Frederic R. Alleva

Center for Drug Evaluation and Research

James A. Vick

Center for Drug Evaluation and Research

Paul Whittaker

Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C. 20204

Jun Zhang

Center for Drug Evaluation and Research

Bert E. Fry, Jr.

Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C. 20204

Tibor Balazs

Center for Drug Evaluation and Research

Asthma morbidity and mortality have risen significantly in the last 10 years. The reasons for the increase are multifactorial. One proposed explanation is possible myocardial toxicity arising from the use of β-agonists alone or in combination with methylxanthines. Previous studies have shown that β-agonists given alone and β-agonist/methylxanthine combinations given at higher than recommended clinical doses induced dose-related cardiotoxicity and sudden death in rats. The objective of the present study was to determine whether or not β-agonists given alone and in combination with methylxanthines at recommended clinical doses also induce cardiotoxicity and sudden death in rats. The β-agonists, isoproterenol hydrochloride (15 µg/kg), fenoterol hydrobromide (40 µg/kg), and terbutaline hemisulfate (0.4 mg/kg) were given in single sc doses separately and concurrently with the methylxanthines aminophylline hydrate (20 mg/kg) and caffeine (40 mg/kg), which were given ip to a susceptible animal model, the heavy Sprague-Dawley rat. β-agonist-induced myocardial toxicity (necrosis) was observed. The toxicity was enhanced by aminophylline resulting in the sudden death (most likely due to ventricular fibrillation) of some animals. A decrease in serum iron levels was observed in rats of all β-agonist and/or methylxanthine-treated groups.

Key Words: β-agonists • methylxanthines • heavy rats • myocardial necrosis • serum ions

Toxicologic Pathology, Vol. 22, No. 1, 72-76 (1994)
DOI: 10.1177/019262339402200110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?